{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T15:47:45Z","timestamp":1764172065501},"reference-count":27,"publisher":"Public Library of Science (PLoS)","issue":"12","license":[{"start":{"date-parts":[[2012,12,6]],"date-time":"2012-12-06T00:00:00Z","timestamp":1354752000000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/publicdomain\/zero\/1.0\/"}],"content-domain":{"domain":["www.plosntds.org"],"crossmark-restriction":false},"short-container-title":["PLoS Negl Trop Dis"],"DOI":"10.1371\/journal.pntd.0001940","type":"journal-article","created":{"date-parts":[[2012,12,6]],"date-time":"2012-12-06T21:55:33Z","timestamp":1354830933000},"page":"e1940","update-policy":"http:\/\/dx.doi.org\/10.1371\/journal.pntd.corrections_policy","source":"Crossref","is-referenced-by-count":29,"title":["Antibody to the Filarial Antigen Wb123 Reflects Reduced Transmission and Decreased Exposure in Children Born following Single Mass Drug Administration (MDA)"],"prefix":"10.1371","volume":"6","author":[{"given":"Cathy","family":"Steel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph","family":"Kubofcik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric A.","family":"Ottesen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas B.","family":"Nutman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2012,12,6]]},"reference":[{"key":"ref1","first-page":"377","article-title":"Global Programme to Eliminate Lymphatic Filariasis: progress report on mass drug administration, 2010","volume":"86","year":"2011","journal-title":"Weekly epidemiological record"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"e317","DOI":"10.1371\/journal.pntd.0000317","article-title":"The global programme to eliminate lymphatic filariasis: health impact after 8 years","volume":"2","author":"EA Ottesen","year":"2008","journal-title":"PLoS Negl Trop Dis"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"e708","DOI":"10.1371\/journal.pntd.0000708","article-title":"The economic benefits resulting from the first 8 years of the Global Programme to Eliminate Lymphatic Filariasis (2000\u20132007)","volume":"4","author":"BK Chu","year":"2010","journal-title":"PLoS Negl Trop Dis"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/S0169-4758(97)01130-7","article-title":"The ICT Filariasis Test: A rapid-format antigen test for diagnosis of bancroftian filariasis","volume":"13","author":"GJ Weil","year":"1997","journal-title":"Parasitol Today"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1475-2883-3-9","article-title":"Recombinant antigen-based antibody assays for the diagnosis and surveillance of lymphatic filariasis - a multicenter trial","volume":"3","author":"PJ Lammie","year":"2004","journal-title":"Filaria J"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/S0065-308X(05)61010-X","article-title":"Lymphatic filariasis: Treatment, control and elimination","volume":"61","author":"EA Ottesen","year":"2006","journal-title":"Adv Parasitol"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"229","DOI":"10.4269\/ajtmh.2011.11-0029","article-title":"Multiplex bead assay for serum samples from children in haiti enrolled in a drug study for the treatment of lymphatic filariasis","volume":"85","author":"DM Moss","year":"2011","journal-title":"Am J Trop Med Hyg"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1016\/S0140-6736(06)68426-2","article-title":"Effect of yearly mass drug administration with diethylcarbamazine and albendazole on bancroftian filariasis in Egypt: a comprehensive assessment","volume":"367","author":"RM Ramzy","year":"2006","journal-title":"Lancet"},{"key":"ref9","article-title":"A multicenter evaluation of a new antibody test kit for lymphatic filariasis employing recombinant Brugia malayi antigen Bm-14","author":"GJ Weil","year":"2010","journal-title":"Acta Trop"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1475-2883-6-10","article-title":"Pan LF-ELISA using BmR1 and BmSXP recombinant antigens for detection of lymphatic filariasis","volume":"6","author":"R Abdul Rahman","year":"2007","journal-title":"Filaria J"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.diagmicrobio.2010.07.015","article-title":"Evaluation of synthetic peptides of WbSXP-1 for the diagnosis of human lymphatic filariasis","volume":"68","author":"P Pandiaraja","year":"2010","journal-title":"Diagn Microbiol Infect Dis"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1111\/j.1348-0421.2009.00114.x","article-title":"Immunolocalization and serum antibody responses to Brugia malayi pepsin inhibitor homolog (Bm-33)","volume":"53","author":"NS Krushna","year":"2009","journal-title":"Microbiol Immunol"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/j.trstmh.2005.08.015","article-title":"Bancroftian filariasis: effect of repeated treatment with diethylcarbamazine and albendazole on microfilaraemia, antigenaemia and antifilarial antibodies","volume":"100","author":"H Helmy","year":"2006","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"e344","DOI":"10.1371\/journal.pntd.0000344","article-title":"The impact of repeated rounds of mass drug administration with diethylcarbamazine plus albendazole on bancroftian filariasis in Papua New Guinea","volume":"2","author":"GJ Weil","year":"2008","journal-title":"PLoS Negl Trop Dis"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"e1479","DOI":"10.1371\/journal.pntd.0001479","article-title":"A multicenter evaluation of diagnostic tools to define endpoints for programs to eliminate bancroftian filariasis","volume":"6","author":"K Gass","year":"2012","journal-title":"PLoS Negl Trop Dis"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1586\/erv.10.50","article-title":"Antibody-profiling technologies for studying humoral responses to infectious agents","volume":"9","author":"PD Burbelo","year":"2010","journal-title":"Expert Rev Vaccines"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"953","DOI":"10.4269\/ajtmh.1982.31.953","article-title":"Endemic filariasis on a Pacific Island. II. Immunologic aspects: immunoglobulin, complement, and specific antifilarial IgG, IgM, and IgE antibodies","volume":"31","author":"EA Ottesen","year":"1982","journal-title":"Am J Trop Med Hyg"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1093\/infdis\/174.3.598","article-title":"Evidence for protective immunity to bancroftian filariasis in the Cook Islands","volume":"174","author":"C Steel","year":"1996","journal-title":"J Infect Dis"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1086\/321004","article-title":"Evolution of immunologic responsiveness of persons living in an area of endemic bancroftian filariasis: a 17-year follow-up","volume":"184","author":"C Steel","year":"2001","journal-title":"J Infect Dis"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"942","DOI":"10.4269\/ajtmh.1982.31.942","article-title":"Endemic filariasis on a Pacific island. I. Clinical, epidemiologic, and parasitologic aspects","volume":"31","author":"PF Weller","year":"1982","journal-title":"Am J Trop Med Hyg"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1093\/infdis\/158.5.1034","article-title":"Enhanced diagnostic specificity in human filariasis by IgG4 antibody assessment","volume":"158","author":"RB Lal","year":"1988","journal-title":"J Infect Dis"},{"key":"ref22","first-page":"79","article-title":"Global programme to eliminate lymphatic filariasis - monitoring and epidemiological assessment of mass drug administration: a manual for national elimination programmes","volume":"4","year":"2011","journal-title":"WHO\/HTM\/NTD\/PCT; Geneva, Switzerland"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"924","DOI":"10.4269\/ajtmh.2008.78.924","article-title":"Impact of five annual rounds of mass drug administration with diethylcarbamazine and albendazole on Wuchereria bancrofti infection in American Samoa","volume":"78","author":"JL Liang","year":"2008","journal-title":"Am J Trop Med Hyg"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"e696","DOI":"10.1371\/journal.pntd.0000696","article-title":"Lymphatic filariasis control in Tanzania: effect of repeated mass drug administration with ivermectin and albendazole on infection and transmission","volume":"4","author":"PE Simonsen","year":"2010","journal-title":"PLoS Negl Trop Dis"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"289","DOI":"10.4269\/ajtmh.2008.78.289","article-title":"Mass drug administration trial to eliminate lymphatic filariasis in Papua New Guinea: changes in microfilaremia, filarial antigen, and Bm14 antibody after cessation","volume":"78","author":"DJ Tisch","year":"2008","journal-title":"Am J Trop Med Hyg"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.trstmh.2010.02.007","article-title":"Filarial selenium glutathione peroxidase: a probable immunodiagnostic marker for lymphatic filariasis","volume":"104","author":"A Singh","year":"2010","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"498","DOI":"10.4269\/ajtmh.2001.65.498","article-title":"Worm burden and host responsiveness in Wuchereria bancrofti infection: use of antigen detection to refine linear assessments from the South Pacific","volume":"65","author":"C Steel","year":"2001","journal-title":"Am J Trop Med Hyg"}],"container-title":["PLoS Neglected Tropical Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pntd.0001940","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,6]],"date-time":"2019-07-06T19:49:41Z","timestamp":1562442581000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pntd.0001940"}},"subtitle":[],"editor":[{"given":"Charles D.","family":"Mackenzie","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2012,12,6]]},"references-count":27,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2012,12,6]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pntd.0001940","relation":{},"ISSN":["1935-2735"],"issn-type":[{"value":"1935-2735","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,12,6]]}}}